The Medicaid expansion has unequivocally been the most successful part of the Affordable Care Act, and the best part to build upon.
Health and Social Policy
Posted inHealth and Social Policy
The Medicare-for-All Real Deal
It’s past time to dispense with the scare tactics and accept that Americans would be better off without for-profit, corporate insurers.
Posted inHealth and Social Policy
Americans Can’t Wait for Washington to Design Family Care Programs When States Have Tools to Act
Democratic presidential candidates finally tackled family leave in the November debate, but a major study shows that states can take steps now to address caregiving needs.
Posted inHealth and Social Policy
A Road Map to Warren’s Entire Administration
The presidential candidate’s Medicare for All transition plan is a muddle. But it reveals her theory of progress.
Posted inHealth and Social Policy
How Elizabeth Warren Misread the Politics of Health Care
She got caught in a policy duel with herself, and was late to understanding how important health care is to the Democratic base.
Posted inHealth and Social Policy
Big Pharma Keeps Bankrolling House GOP’s Dark Money Arm
The leading pharmaceutical lobby gave to numerous Republican groups—and one key Democratic one.
Posted inHealth and Social Policy
Ridiculous D.C. Invite of the Week: Innovating Health Innovation, Innovatively
A Capitol Hill briefing is more like lobbying in another form.
Posted inHealth and Social Policy
The Great Fairness Versus Disruption Debate
Elizabeth Warren’s and Bernie Sanders’s Medicare for All funding plans reveal strategic differences among progressives.
Posted inHealth and Social Policy
Warren’s Medicare for All Plan Includes No New Taxes on the Middle Class
The deeply detailed proposal cuts health care costs and finds other revenues, saving ordinary Americans $11 trillion in premiums and deductibles.
Posted inHealth and Social Policy
When Pharma Needs a Friend: Conservative House Democrats Move to Protect Drug Company Profits
A letter from 11 Democrats expresses support for a drug patent provision in the NAFTA update that most of their caucus opposes.
